# EDGAR Filing Document

**Accession Number:** 0001137774
**File Stem:** 0001127602-23-001243
**Filing Date:** 2023-1
**Character Count:** 10988
**Document Hash:** 55fdf2307b9755979cf75b91102d2609
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-001243.hdr.sgml**: 20230110

**ACCESSION NUMBER**: 0001127602-23-001243

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230101

**FILED AS OF DATE**: 20230110

**DATE AS OF CHANGE**: 20230110

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Feeney Caroline
- **CENTRAL INDEX KEY:** 0001960842

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16707
- **FILM NUMBER:** 23521967

**MAIL ADDRESS:**
- **STREET 1:** 751 BROAD STREET, 5TH FLOOR
- **STREET 2:** ATTN: REGULATORY FILINGS UNIT
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRUDENTIAL FINANCIAL INC
- **CENTRAL INDEX KEY:** 0001137774
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **IRS NUMBER:** 223703799
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 751 BROAD ST
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102
- **BUSINESS PHONE:** 9738026000

**MAIL ADDRESS:**
- **STREET 1:** 751 BROAD ST
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102

## Ex-24

```

EXHIBIT 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes
and appoints each of Margaret M. Foran, Richard J. Baker, and Danny Fiore,
signing singly, the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Prudential Financial, Inc. (the "Company"),
Forms 3, 4, and 5 (and any other Form that may be required by the Securities
and Exchange Commission) in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and Form 144 in accordance with Rule 144 of the Securities
Act of 1933 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Section 16(a)
Form or Form 144, complete and execute any amendment or amendments thereto, and
timely file such form with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation
and resubstitution, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934 and Rule 144 of the Securities Act of 1933.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to make filings pursuant to Section 16(a) and
Rule 144 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

This Power of Attorney shall be governed by and construed in accordance with New
Jersey law.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 3rd day of January, 2023.

/s/Caroline Feeney
Signature

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Feeney Caroline<br><sub>(Last) (First) (Middle)</sub><br>751 BROAD STREET, 5TH FLOOR<br>ATTN.: REGULATORY FILINGS UNIT<br><sub>(Street)</sub><br>NEWARK, NJ 07102<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>PRUDENTIAL FINANCIAL INC [ PRU ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Executive Vice President_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 5126 | D |  |
| Common Stock | 7541 | I | By 401(k) |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 2017 Employee Stock Option (Right to Buy) | <sup>(1)</sup> | 2027-02-14 | Common Stock | 2117 | $110.45 | D |  |
| 10/2/17 Employee Stock Option (Right to Buy) | <sup>(2)</sup> | 2027-10-02 | Common Stock | 1222 | $107.28 | D |  |
| 2018 Employee Stock Option (Right to Buy) | <sup>(3)</sup> | 2028-02-13 | Common Stock | 2926 | $106.89 | D |  |
| 2019 Employee Stock Option (Right to Buy) | <sup>(4)</sup> | 2029-02-12 | Common Stock | 5016 | $93.36 | D |  |
| 2020 Employee Stock Option (Right to Buy) | <sup>(5)</sup> | 2030-02-11 | Common Stock | 7883 | $95.87 | D |  |
| 2020 Performance Share | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 8762 | <sup>(7)</sup> | D |  |
| 6/12/2018 Employee Stock Option (right to buy) | <sup>(8)</sup> | 2028-06-12 | Common Stock | 397 | $99.76 | D |  |
| 2021 Performance Shares | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 12035 | <sup>(10)</sup> | D |  |
| 2021 Restricted Stock Units | <sup>(11)</sup> | <sup>(11)</sup> | Common Stock | 3439 | 0<sup>(12)</sup> | D |  |
| 2022 Performance Shares | <sup>(13)</sup> | <sup>(13)</sup> | Common Stock | 15578 | <sup>(14)</sup> | D |  |
| 2022 Restricted Stock Units | <sup>(15)</sup> | <sup>(15)</sup> | Common Stock | 6677 | 0<sup>(16)</sup> | D |  |
| 1/12/21 Restricted Stock Units | <sup>(17)</sup> | <sup>(17)</sup> | Common Stock | 60761 | <sup>(16)</sup> | D |  |

---

### Footnotes:

(1) The options vest in three equal annual installments beginning on February 14, 2018

(2) The options vest in three equal annual installments beginning on October 2, 2018

(3) The options vest in three equal annual installments beginning on February 13, 2019.

(4) The options vest in three equal annual installments beginning on February 12, 2020.

(5) The options vest in three equal annual installments beginning on February 11, 2021.

(6) Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023.

(7) The performance shares convert to common stock on a 1 to 1 basis.

(8) The options vest in three equal annual installments beginning on June 12, 2019.

(9) Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier.

(10) Performance shares convert to common stock on a 1 to 1 basis

(11) The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022.

(12) The Restricted Stock Units convert to common stock on a 1 to 1 basis.

(13) Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period.

(14) Performance shares convert to common stock on a 1 to 1 basis.

(15) The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023.

(16) The Restricted Stock Units convert to common stock on a 1 to 1 basis.

(17) The Restricted Stock Units will vest on 1/12/26

**Signature:** /s/ Richard J. Baker, attorney-in-fact  
**Date:** 2023-01-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**